Clinical Trial Update: Trial of Melatonin to Improve Sleep in Children With Epilepsy and Neurodevelopmental Disabilities [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating melatonin to improve sleep in children with epilepsy and neurodevelopmental disabilities has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Developmental Disability
• Epilepsy
• Insomnia

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Epilepsy, Insomnia | Phase 3 | Status: COMPLETED